Washington, D.C. , 06 February (H.S.): Newly unsealed medical records from the U.S. Department of Justice, released as part of the ongoing Epstein Files Transparency Act disclosures, have unveiled financier Jeffrey Epstein's protracted battle with severely deficient testosterone levels, multiple sexually transmitted infections, and futile attempts at hormonal remediation, casting fresh shadows on his tumultuous personal health narrative.

These documents, made public in tranches totaling millions of pages—including emails, test results, and physician correspondences—detail testosterone measurements consistently languishing between 125 and 142 nanograms per deciliter across several years, plummeting well beneath the American Urological Association's threshold of 300 ng/dL for clinical hypogonadism.

In a candid April 2015 email dispatched at 3 a.m. to his physician, Epstein lamented the persistence of this affliction, noting it had remained the same for ten years and querying whether his low testosterone has caught up to him, thereby humanizing yet complicating the profile of the convicted sex offender who perished in federal custody on August 10, 2019.

Medical advisors prescribed interventions such as Clomid, a selective estrogen receptor modulator typically employed to stimulate endogenous testosterone production, but Epstein discontinued the regimen by 2016, decrying side effects including pronounced fluid retention and abdominal fat accumulation that rendered him feeling as if I was pregnant.

Compounding these endocrine woes, the files chronicle diagnoses of gonorrhea—confirmed via a 2016 blood test revealing gonococcus in semen—alongside parasitic infestations like whipworm and histolytica, hematuria, and a history of bladder polyps; Epstein promptly underwent antibiotic therapy with 1 gram of ceftriaxone and 2 grams of azithromycin.

Further disclosures reveal Epstein's receipt of promotional solicitations for sexual enhancement supplements and inquiries into sperm cryopreservation, underscoring preoccupations with virility amid his documented libido impairments.

This cascade of intimate health particulars emerged from the Epstein Files Transparency Act—signed into law by President Donald Trump in November 2025—mandating the DOJ's release of unclassified investigative materials encompassing court filings, grand jury transcripts, flight logs, and electronic communications amassed over decades, with over 3.5 million pages now digitized for public scrutiny despite redactions to shield victims.

The revelations, scrutinized by Deputy Attorney General Todd Blanche as fulfilling congressional imperatives for transparency, continue to ripple through public discourse, intertwining Epstein's physiological frailties with the enduring saga of his sex-trafficking empire and associations with high-profile figures.

---------------

Hindusthan Samachar / Jun Sarkar